Terms: = Gastric cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Prognosis
11 results:
1. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
Pyo JS; Kim NY; Min KW; Kang DW
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
[No Abstract] [Full Text] [Related]
2. Impact of metabolic syndrome on the short- and long-term outcomes for the elderly patients with gastric cancer after radical gastrectomy.
Wu H; Jiang HJ; Wang SL; Chen XY; Ma LL; Yu Z; Zhou CJ
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102041. PubMed ID: 36273756
[TBL] [Abstract] [Full Text] [Related]
3. Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal cancer.
Booka E; Kikuchi H; Haneda R; Soneda W; Kawata S; Murakami T; Matsumoto T; Hiramatsu Y; Takeuchi H
Anticancer Res; 2022 Jun; 42(6):2977-2987. PubMed ID: 35641297
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of treatment strategies and survival of early-onset gastric cancer: a population-based study.
Zhang C; Tang R; Zhu H; Ge X; Wang Y; Wang X; Miao L
Sci Rep; 2022 Apr; 12(1):6288. PubMed ID: 35428811
[TBL] [Abstract] [Full Text] [Related]
5. Neutrophil-to-lymphocyte ratio and C-reactive protein-to-albumin ratio as prognostic factors for unresectable advanced or recurrent gastric cancer.
Namikawa T; Shimizu S; Yokota K; Tanioka N; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Langenbecks Arch Surg; 2022 Mar; 407(2):609-621. PubMed ID: 34652563
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological significance and prognostic role of microvessel density in gastric cancer: A meta-analysis.
Hong WG; Ko YS; Pyo JS
Pathol Res Pract; 2017 Dec; 213(12):1459-1463. PubMed ID: 29129495
[TBL] [Abstract] [Full Text] [Related]
7. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract] [Full Text] [Related]
8. Cumulative Metformin Use and Its Impact on Survival in gastric cancer Patients After Gastrectomy.
Lee CK; Jung M; Jung I; Heo SJ; Jeong YH; An JY; Kim HI; Cheong JH; Hyung WJ; Noh SH; Kim HS; Rha SY; Chung HC
Ann Surg; 2016 Jan; 263(1):96-102. PubMed ID: 25575260
[TBL] [Abstract] [Full Text] [Related]
9. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
Li Z; Zou X; Xie L; Chen H; Chen Y; Yeung SC; Zhang H
Int J Cancer; 2015 Apr; 136(7):1636-45. PubMed ID: 25159681
[TBL] [Abstract] [Full Text] [Related]
10. Reduced expression of MUTYH with suppressive activity against mutations caused by 8-hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer.
Shinmura K; Goto M; Suzuki M; Tao H; Yamada H; Igarashi H; Matsuura S; Maeda M; Konno H; Matsuda T; Sugimura H
J Pathol; 2011 Nov; 225(3):414-23. PubMed ID: 21826668
[TBL] [Abstract] [Full Text] [Related]
11. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients.
Nakane Y; Okamura S; Akehira K; Boku T; Okusa T; Tanaka K; Hioki K
Cancer; 1994 Jun; 73(11):2703-8. PubMed ID: 8194009
[TBL] [Abstract] [Full Text] [Related]
